Study On Financing Of Jilin Yinglian Biological Pharmaceutical Corporate

The biological technology will be the new century the most the prospects of development of new and high technology fields,it is in the world recognized as "sunrise enterprise", is a matter of national economy and people’s livelihood strategic industry, and the related biological pharmaceutical industry also prospects the infinite.YL Biological Pharmaceutical Corporate has innate resource advantages,and the biological pharmaceutical field has the advantageous conditions. But the financing problem has been troubling YL Biological Pharmaceutical Corporate this also is in the present Ji Lin or even Chinese small and medium-sized biological pharmaceutical enterprise development the main reason behind.Based on the analysis of the YL Biological Pharmaceutical Corporate financing status and structure of the thesis, hoping to find a suitable YL Biological Pharmaceutical Corporate financing channels. The main source of YL Biological Pharmaceutical Corporate financing needs in three aspects: first, the construction and further development of existing products production line; second, the development of innovative drugs; third, industry mergers and acquisitions. YL Biological Pharmaceutical Corporate in solving the financing problem mainly depends on the entrepreneur’s self financing and national science and technology subsidies, but these funds could not meet the needs of the development of bio pharmaceutical enterprises. Through the research on the financing mode of YL Biological Pharmaceutical Corporate financing has the following five aspects: first, the concept of financing is too narrow, the financing channel is single; second, debt financing ability is insufficient; third, the investment risk investment of small and medium-sized enterprises lack of confidence, not easily get involved; fourth, insufficient government investment; fifth, loan low efficiency and high cost.This paper mainly uses the empirical research method and comparative research method of two kinds of methods, and analyzes the main factors influencing the YL Biological Pharmaceutical Corporate financing is divided into three aspects:(1) the influence of the bio pharmaceutical industry;(2) internal factors;(3) factors affecting the surrounding financing environment.Through the analysis of the causes of the problems and put forward reasonable suggestions and corresponding financing strategy, enrich the financing structure, to broaden the financing channels is a major problem in the future YL Biological Pharmaceutical Corporate to solve the financing. YL Biological Pharmaceutical Corporate choose the following financing: first, internal financing, second, debt financing, third, Venture Capital, fourth, Public financing, fifth, the application of Science and Technology Innovation Fund, to increase government funding the risk of investment, financing, including financing should be listed on the main board of the positive development of YL Biological Pharmaceutical Corporate target.